Week 2 Flashcards

1
Q

Where do mature B-cells reside?

A

Secondary lymphoid organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is B-cell activation?

A
  • A naiive B-cell has not yet recognized its antigen
  • When a naive B-cell binds to its antigen, it becomes activated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is cross-linking?

A
  • When multiple BCR’s on a single B-cell, all with the same specificity, bind to the antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is activation signals conveyed to naive B-cell when it binds its antigen?

A
  • Ig-alpha
  • Ig-beta
  • Non-covalently associated with BCR and they are responsible for signaling cascade within B-cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the result of B-cell activation?

A
  • B-cell turns into a plasma cell that secretes antibodies
  • Antibodies have the exact same specificity as the BCR receptor. The only difference between antibodies and BCR is they are secreted instead of tethered to the membrane.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Structure of antibodies

A
  • 2 light chains
  • 2 heavy chains
  • Variable regions and constant regions
  • Each antibody has 2 antigen-binding sites (variable regions)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

antigen binding site of BCR/antibodies

A
  • There are 2 antigen binding sites
  • Each site is made up of 1 variable region of a light chain and 1 variable region of a heavy chain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

hypervariable loops of BCR/antibody

A
  • There are 3 hypervariable loops within each V region
  • So there are 6 hypervariable loops per antigen-binding site
  • These are also called “Complementarity determining regions”
  • This is the specific region within the V region that binds the antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do the hypervariable loops recognize?

A
  • Epitope - the specific region of an antigen that the hypervariable region binds to
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

linear epitope

A
  • a linear sequence of amino acids recognized by an antibody
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

discontinuous epitope

A
  • a sequence of amino acids within the antigen’s folded shape.
  • recognized by a BCR/antibody
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

multivalent antigen

A
  • When an epitope is present multiple times on a single antigen, we call it a multivalent antigen
  • BCR stimulation is stronger with a multivalent antigen
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Can multiple antibodies bind to the same antigen?

A
  • Yes
  • BCR A binds to epitope A and BCR B binds to epitope B on the same antigen.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

polyclonal response

A
  • When multiple different types of B-cells are activated in resopnse to a single antigen
  • Antibodies with the same V-region and antigen specificity can bind to an antigen. But these antibodies can have different C-regions, which dictates the host’s response to the antigen.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What dictates the immune response to an antibody binding the antigen?

A
  • The C-region of the bound antibody
  • The “class” of antibody bound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 5 isotypes/classes of antibodies?

A
  • IgG
  • IgA
  • IgM
  • IgD
  • IgE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the structure of IgM?

A
  • Pentamer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the structure of IgA?

A

dimeric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the first antibody isotype produced in an immune response? Why?

A
  • IgM
  • Because it is a pentamer, it has 10 antigen binding sites
  • It binds with high avidity and can produce a strong response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the 3 ways that antibodies participate in immune response?

A
  1. Neutralization - bind pathogen/toxins to prevent the pathogen binding to host cells
  2. Opsonization - bind pathogen directly to mark it for phagocytosis
  3. Activate complement system - results in lysis and phacocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which antibodies participate most in neutralization? Why?

A
  • IgG
  • IgA
  • These are high affinity antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Where is IgA found?

A
  • Mucosa (respiratory tract, GI tract)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Examples of IgA participating in host defense via neutralization

A
  • Strep
  • Influenza
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which antibodies participate in complement fixation?

A
  • IgM - C1q binds to IgM and initiates classical pathway
  • IgG - C1q binds to two or more IgG and initiates classical complement pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Why would IgA NOT be a part of complement fixation?

A
  • It is found in the mucosa, whereas complement proteins are floating around in the blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Fc receptors

A
  • Are found on innate immune cells (macrophages, neutrophils, NK cells)
  • Fc receptors recognize and bind the constant region of the antibody (with antigen bound)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which antibody isotypes/classes can Fc receptors on innate cells recognize?

A
  • IgG
  • IgA
  • IgE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What happens when Fc receptor binds C region of IgG?

A
  • phacocytosis by macrophages
  • killing by natural killer cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is a cell’s response to Fc receptor binding IgE?

A
  • degranulation of eosinophils
  • degranulation of mast cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How are monoclonal antibodies produced?

A
  • B-cell hybridoma technology
  • Inject a pathogen into an animal –> polyclonal response
  • Isolate the specific B-cell clone that you want
  • Fuse the B-cell clone with a myeloma cell –> “an immortal B-cell” with a single specificity = monoclonal antibody
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

chimeric monoclonal antibodies

A
  • The V-regions are from a mouse
  • The rest of the antibody is from a human
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

humanized monoclonal antibodies

A
  • The hypervariable regions are from a mouse
  • The rest is from a human
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

human monoclonal antibodies

A
  • The whole antibody is human but is produced in a mouse
  • You alter mice antibody genes to produce human antibody genes
  • This is the least immunogenic of the monoclonal antibodies, but it has ethical considerations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

ELISA

A
  • Used for DETECTION of antibodies and antigens in the blood
  • Coat the antigen onto some sort of sticky surface
  • Direct and indirect ELISA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Direct ELISA

A
  • Coat antigen onto a sticky surface
  • An antibody specific to your antigen of interest is tagged with an enzyme
  • Incubate antibody with antigen-coated surface
  • Add enzyme’s substrate
  • If there is a color change –> your antibody is detecting the antigen it binds to.
  • The more the color change, the more antibody (and antigen) is present in that sample.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Indirect ELISA

A
  • Coat sticky surface with antigen/sample of patient’s blood
  • Add a primary monoclonal antibody specific to antigen of interest that you’re testing for
  • Add a secondary POLYCLONAL antibody that binds to the primary monoclonal antibody. The secondary antibody is the one tagged with an enzyme
  • Several of these secondary antibodies will bind to the primary enzyme, which increases the sensitivity of the test (more likely to get a positive test if the antigen is present).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Sandwich ELISA

A
  • A form of indirect ELISA
  • Coat sticky surface with a monoclonal antibody
  • Add the sample
  • If antigen is present, it will bind monoclonal antibody
  • Use a primary monoclonal antibody that will bind antigen a second time
  • Use secondary polyclonal antibody with the enzyme
  • This increases sensitivity AND specificity over standard direct ELISA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is ELISA used for?

A
  • HIV detection
    • Viral antigens themselves
    • Antibodies produced from HIV infection
  • ELISA has high sensitivity and is used for initial screening for HIV. Diagnosis is confirmed using RT-PCR, which is more specific.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What kind of ELISA is used for HIV screening?

A
  • Sandwich ELISA
  • gp120 is considered the “capture antibody”
  • The antigen being measured here is the patient’s antibodies against HIV viral protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Flow cytometry

A
  • Main purposes is to detect changes or particular subsets of cells in the blood (i.e. allows you to count things)
  • Main application: you can’t see what kind of leukocytes are present under a microscope. This method allows you to figure that out.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

how does flow cytometry work?

A
  • Use flourophore molecules that have Ab conjugated to them.
  • The antibodies are specific for proteins on the surface of immune cells.
  • So Ab-flourophore1 binds to type 1 immune cells. Ab-flourophore2 binds to type 2 immune cells.
  • Then you send the cell-Ab-flourophore through a detector that spits out results onto a dot plot that you can read to see which immune cells and how many are present.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What do we use flow cytometry for?

A
  1. X-linked agammaglobulinemia
  • This is a disease where you don’t produce B-cells
  • You use flow cytometry to check and can see that basically there are no B-cells in patient’s blood
  1. CD4 T-cell count in HIV
    * Used to monitor their T-cell count
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

How is the heavy chain different from the light chain in B-cell genes?

A
  • It has a diversity gene segment
  • There is only 1 heavy chain locus but 2 light chain loci
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What is somatic recombination?

A
  • Used by B-cells and T-cells to produce receptors with a wide array of specificity
  • This is basically DNA splicing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Process of Light chain recombination for B-cells

A
  1. V and J segments are selected at random and recombined first. This is the ONLY recombination event for light chains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is the process of heavy chain somatic recombination for BCRs?

A
  1. First recombination is to join a D segment to a J segment
  2. Second recombination combes DJ segment to a V segment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What is the main difference between light chain and heavy chain recombination in BCRs?

A
  • The light chain undergoes only 1 recombination event (VJ)
  • The heavy chain undergoes 2 recombination events (DJ then VDJ)
  • The light chain has no D region
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What are the enzymes that carry out somatic recombination in BCRs?

A

recombinases (RAG enzymes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

what do recombinase enzymes recognize?

A
  • recombination signal sequences (RSS) in the DNA flanking V,D, and J segments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What is the signal joint?

A
  • The DNA that is cleaved out during somatic recombination of BCRs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What is the coding joint?

A
  • The area that is joined together to form the recombined VJ segment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Non-homologous end joining

A
  • The process by which broken strands of DNA are rejoined during somatic recombination
  • This rejoining is done by DNA repair enzymes, NOT RAG enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What is the major source of diversity in BCRs outside of somatic recombination?

A

junctional diversity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

junctional diversity

A
  • The process by which random nucleotides are added between V-J regions (in the light chain) and D-J/V-DJ regions in the heavy chain
  • A major source of BCR diversity in antigen binding site specificity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

terminal deoxy-nucleotidyl transferse (TdT)

A
  • The enzyme that adds the nucleotides in junctional diversity process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Overview of BCR somatic recombination for both heavy and light chains

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Stages of B-cell development timed with heavy chain/light chain rearrangement

A
  • Immature B-cell is the stage when the heavy chain and light chains have paired up
  • This is when you have a functional BCR that can be trafficked to the cell surface
  • B-cells remain immature as long as they’re in the bone marrow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

what are the earliest identifiable cells of the B-cell lineage?

A
  • early pro-B cells
  • Heavy chain DJ rearrangement has occurred
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What cells support B-cell development?

A
  • stromal cells (in the bone marrow)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Why is B-cell somatic recombination of the heavy chain inherently imprecise and inefficient?

A
  • Junctional diversity can add nucleotides in such a way that the reading frame of the entire gene is shifted
  • This frequently results in nonproductive rearrangements
  • B-cells that have one nonproductive rearrangement can try again on the other chromosome. If both fail, that B-cell dies.
  • About half of developing B-cells die at the pro-B cell stage (due to nonproductive DJ rearrangement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What is the pre-B cell stage?

A
  • heavy chain rearrangement has occurred successfully (DJ and VDJ rearrangements)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What must occur for a pro-B cell to proceed to pre-B cell stage?

A
  • A pro-B cell must have undergone heavy chain rearrangement to form VDJ segment AND
  • A surrogate light chain (SLC) must be made to pair up with the heavy chain while the real light chain is being recombined
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

what is allelic exclusion?

A
  • Expression of only one of two copies of a gene (present on separate chromosomes) is allelic exclusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

When do we see allelic exclusion in B-cell development?

A
  • When a functional heavy chain is made and a surrogate light chain pairs with it, you have a pre-B cell.
  • At this stage, RAG enzymes are turned off to prevent any further rearrangement of the heavy chain on the other chromosome. That is allelic exclusion
  • This ALSO happens for the light chain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

why is light chain rearrangement more successful than heavy chain in B-cell development?

A
  • Heavy chain only has 1 locus. Failure at one chromosome gives only one other chance (on the other chromosome).
  • Light chain has 2 different loci. If rearrangement is nonproductive at light chain locus #1, then the cell keeps trying.
  • If there are multiple failures, the next locus is tried.
  • **The light chain can try multiple times at a locus, but the heavy chain only tries once**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

what is the purpose of heavy chain allelic exclusion vs light chain allelic exclusion?

A
  • Heavy chain allelic exclusion occurs so that heavy chain rearrangement is turned off after a functional heavy chain is made. This ensures only one type of BCR is made.
  • Light chain allelic exclusion occurs after a fully functional BCR is made. This ensures that each B-cell only expresses one type of BCR.
  • Together, allelic exclusion at the heavy-chain and then light-chain Ig loci ensures expression and secretion of Igs of a single antigen-specificity in individual B cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What are the 2 developmental checkpoints in B-cell development?

A
  1. Heavy chain expression inside the B-cell –> pairing of SLC (and progression to pre-B cell stage). No pairing –> death.
  2. Light chain expression inside the B-cell –> functional B-cell receptor (and progression to immature B-cell stage).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

B-cell central tolerance

A
  • The process of making sure B-cells do not attack self
  • This all occurs in the bone marrow as part of B-cell development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

What happens if a B-cell is strongly self-reactive in the bone marrow?

A
  • First it’s given a chance to rearrange the light chain - this is called “B cell editing”
  • If that doesn’t work, it undergoes apoptosis
  • These B-cells that are strongly reactive are ones that recognize multivalent self molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What happens if a B-cell is moderately self-reactive in the bone marrow?

A
  • It is modified to be unreactive but then is still sent to the periphery
  • An unresponsive B-cell in the periphery is called anergic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

What happens to an immature B-cell that is not reactive towards self in the bone marrow?

A
  • It is sent to the periphery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

How do autoimmune conditions develop?

A
  • One way is that B-cells can escape central tolerance
  • B-cells sometimes don’t encounter all possible self molecules inside the bone marrow (like insulin). When it is sent to the periphery, it can encounter them and react towards them.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Ignorant B-cells

A
  • Self-specific B cells that do not encounter self-antigen in the bone marrow are called ignorant.
  • These can encounter self antigen outside the bone marrow and be reactive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Types of B-cells that can be responsible for autoimmune issues

A
  • Anergic B cells
  • Ignorant B-cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Overview of B-cell central tolerance

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

What does occupancy depend on?

A
  • Concentration of drug
  • Affinity of receptor (Kd)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

What does strength of drug stimulug depend on?

A
  • The number of receptors
  • The intrinsic efficacy of the drug-receptor complex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

What does the cell’s response to the stimulus depend on?

A
  • Strength of stimulus
  • Tissue sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Formula to determine fractional occupancy

A
  • Can determine by knowing concentration of the drug and the Kd
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

why would you want to know fractional occupancy?

A
  • Can help you determine the total number of receptors that are occupied (which is important in knowing the stimulus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Definition of Kd

A
  • The drug concentration needed in order to have 50% of receptors occupied
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Definition of Ec50/Ed50

A
  • Ec50 = Concentration of drug required to generate a half maximal response
  • Ed50 = dose of drug required to generate a half maximal response
  • **These two things are different. Dose is what is taken. Concentration is at the site of action.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

What does Ec50 tell you?

A
  • A measure of the drug’s potency
  • Lower Ec50 = higher potency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

stimulus

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

what is receptor reserve?

A
  • When Ec50 is reached before Kd
  • You get a half maximal response before you occupy 50% of receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

What causes receptor reserve?

A
  • The tissue is very sensitive
  • The intrinsic efficacy of drug-receptor complex is high
  • You have lots of receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

What determines the potency of the drug?

A
  • Affinity of receptor (Kd)
  • Total number of receptors
  • Intrinsic efficacy
  • Sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What determines the maximum response?

A
  • Intrinsic efficacy
  • sensitivity
  • receptor number
  • NOT Kd
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

What types of antagonism are there?

A
  1. surmountable
  2. insurmountable
  3. physiologic antagonism
90
Q

what is physiologic antagonism?

A
  • Two different receptors that cause two different responses can antagonize each other
91
Q

5 main cellular responses to stress

A
  1. hypertrophy
  2. hyperplasia
  3. atrophy
  4. metaplasia
  5. intracellular accumulation of metabolic products
92
Q

hypertrophy

A
  • definition: cells get bigger
  • Can be physiologic (ex: workout out) or pathologic (ex: heart gets bigger in response to hypertension)
93
Q

hyperplasia

A
  • cells get bigger AND there is more of them
  • example of pathologic process: warts from HPV are the result of too much epidermis
94
Q

atrophy

A
  • definition: cells shrink and you have fewer of them
  • example: 80 year old brain is smaller than a 23 year old brain
95
Q

metaplasia

A
  • definition: a change in cell types
  • ex: heartburn causes acid to come out of stomach and into distal esophagus. This acid does not just damage the esophageal cells, it turns them from squamous epithelium to columnar epithelium.
96
Q

What are the first changes you see in an injured cell?

A
  • Biochemical changes happen first
  • Changes visible in light microscopy and organ level lag behind this
97
Q

What are some of the changes you can see in a microscope when a cell has undergone injury?

A
  1. accumulation of water (hydropic changes)
  2. accumulation of lipid (steatosis)
  3. Glycogen
  4. Protein
  5. Pigments
98
Q

What is the first change you see to damaged cells under a light microscope? Why?

A
  • hydropic changes (accumulation of water)
  • Cell injury often disrupts glycolysis, Krebs, and ETS –> ion balance gets fucked up –> water inside the cell
  • You’ll see clear vacuoles
99
Q

What is lipid accumulation called?

A

steatosis

100
Q

What causes steatosis?

A
  • Genetic disorders
  • alcoholic liver injury
  • obesity
  • diabetes
  • toxins
101
Q

How does steatosis appear in light microscope?

A
102
Q

What is Fabry’s disease? What cellular changes do you see?

A
  • Lysosomal storage disease
  • See an accumulation of glycolipids –> appearance of lipid inclusions
  • Primarily affects heart, kidney, and blood vessels
103
Q

How does glycogen accumulation appear in light microscope?

A
  • Clear vacuoles in cytoplasm
104
Q

what causes glycogen accumulation in cells?

A
  • Glycogen storage disorder
  • Diabetes
105
Q

what causes protein accumulation in cells?

A
  • Resorption
  • Excess synthesis of protein
  • Defects in folding (usually genetic)
  • Aggregation of abnormal proteins
106
Q

Alpha-1-antitrypsin deficiency

A
  • Normal state: liver secretes anti-trypsin to inhibit trypsin, which is an enzyme that breaks down protein. Anti-trypsin prevents trypsin from degrading elastic layers of the lung.
  • Pathology: A mutation in anti-trypsin results in accumulation of non-functional (improperly folded) anti-trypsin in the liver. And you lose lung function b/c trypsin is breaking down lung layers.
  • The anti-trypsin accumulations are seen as big pink globules in the liver.
107
Q

What is alzheimer’s an example of re: cell injury?

A
  • accumulation of protein (amyloid proteins)
108
Q

What is amyloidosis?

A
  • Caused by a malignant plasma cell, which results in the accumulation of protein in the cell
  • specifically, the protein is a build up of light chains
109
Q

What is pathognomonic for amyloidosis?

A
  • Bright luminescence on a congo red stain
110
Q

Intracellular pigments

A
  • Hemosiderin
  • Lipofuscin
  • Melanin
  • Exogenous substances
111
Q

What is hemosiderin? How does it appear under light microscope?

A
  • It is a byproduct of hemoglobin breakdown
  • Externally it appears as bruising
  • Under light microscope it appears as brown pigment
112
Q

Lipofuscin - what does it look like under light microscope, what causes it?

A
  • Caused by normal wear and tear - i.e. this is a physiologic change, NOT pathologic
  • Reddish hue to it
113
Q

anthracosis

A
  • Coal Miner’s lung
  • Example of exonenous substance building up and causing cellular injury
114
Q

Necrosis vs. Apoptosis

A
  • Necrosis is characterized by inflammation; apoptosis is not
  • Necrosis shows hydropic changes; apoptosis shows cell shrinkage
  • Necrosis shows autolysis and leakage of intracellular contents; apoptosis shows nuclear fragments and blebbing)
115
Q

What morphologic changes do you see during necrosis?

A
  • Cytosol: cell swelling (hydropic change), eosinophilia
    • Eosinophilia is a very pink stain of the cells. This is b/c transcription shuts down, and RNA stains blue. But protein stains pink and is more durable than RNA.
  • Nucleus: karyolysis (chromatin fades), pyknosis (nucleus shrinks), karyorhexis (nucleus fragments)
116
Q

Types of necrosis

A
  1. coagulative necrosis
  2. liquefactive necrosis
  3. Caseous necrosis
  4. Gangrenous necrosis
  5. Fibrinoid necrosis
  6. Fat necrosis
117
Q

Coagulative necrosis

A
  • “Death in place”
  • Characterized by ghosts of cells - no nucleus, but the cell architecture remains
118
Q

Most common cause of coagulative necrosis

A
  • Ischemia
    • Heart attack
119
Q

What is a common finding under light microscope of coagulative necrosis?

A
  • Cells are intact but missing nuclei
120
Q

Liquefactive Necrosis

A
  • The tissue dies and then disintegrates, so you just see a void of tissue
121
Q

Most common cases of liquefactive necrosis

A
  • **Stroke
  • Abscess (dead tissue is replaced by pus = neutrophils)
122
Q

Caseous necrosis

A
  • Tissue takes on a cheese-like appearance
  • Dead cells persist but then are surrounded by inflammatory cells
123
Q

Most common causes of caseous necrosis

A
  • Tuberculosis
124
Q

How does caseous necrosis appear under light microscope?

A
  • Central area of dead tissue walled off by inflammatory cells
125
Q

Gangrenous necrosis

A
  • Tissue dies and then is accompanied by bacterial infection
126
Q

Most common cause of gangrenous necrosis

A
  • Diabetes
127
Q

Fibrinoid necrosis

A
  • An accumulation of fibrin in?around the arteriole
  • Only seen in 1 particular setting: vasculitis
128
Q

Fat necrosis

A
  • This is necrosis specifically of adipose tissue
  • Most commonly caused by pancreatic injury –> leakage of digestive enzymes
129
Q

What is the cause of myocardial rupture?

A
  • After a heart attack, the damaged tissue begins remodeling
  • The tissue is much weaker during this time and can result in rupture
  • Often occurs 5-9 days after the heart attack during remodeling phase
130
Q

What is the fate of dead tissue?

A
  1. Eaten up by macrophages and neutrophils
  2. Scarring
  3. Calcifications
131
Q

Chronic Granulomatous Disease cause

A
  • NADPH oxidase disorder
132
Q

Result of defective NADPH oxidase

A
  • Cannot generate reactive oxygen species in phagolysosomes
133
Q

What type of organism are CGD patients most susceptible to?

A
  • catalase positive organisms
  • Because they can break down hydrogen peroxide
  • Results in recurrent fungal infections
134
Q

What is an NBT test?

A
  • Measures the ability of phagocytes to generate reactive oxygen species
  • ROS reduce NBT –> purple color in the neutrophils (normal lab finding)
  • People with CGD can’t reduce NBT, so their neutrophils don’t turn purple/blue
135
Q

Most common genetic cause of CGD?

A
  • Defect in gp91 protein, a component of NADPH oxidase
  • Shows X-linked pattern of inheritance
136
Q

Structure of T-cell receptor

A
  • Membrane-bound
  • Alpha chain and beta chain
  • Variable region and constant region
137
Q

How many antigen-binding sites does a TCR have?

A

One

138
Q

Alpha chain gene rearrangement in TCR

A
  • VJ recombination happens as somatic recombination
  • Primary transcript is made, then extra J regions are spliced
  • There is a single C-region
139
Q

Beta chain rearrangment in TCR

A
  • There are 2 somatic recombinations: DJ followed by VDJ
  • There are 2 clusters of D-J-C regions from which recombination can occur. It’s random as to whether somatic recombination occurs in cluster 1 or cluster 2.
140
Q

What does it mean that there is no isotype switching in TCR?

A
  • The C-regions that can be used for somatic recombination in TCRs are almost identical
  • In BCRs, there are many different types of C-regions that can be spliced with VJ (light chain) or VDJ (heavy chain). This variability of C-regions is responsible for antibody class (IgG, IgM, etc.)
  • In TCRs, there is basically only one constant chain available for the alpha chain and essentially only one for the beta chain, so there are not different “classes” of TCRs.
141
Q

What enzymes are responsible for TCR somatic recombination?

A
  • RAG enzymes
142
Q

Nonsense mutations in RAG genes

A
  • Results in SCID
  • A complete inability to produce an adaptive immune response (have no functional B or T-cells)
143
Q

Missense mutations in RAG genes

A
  • Results in Omenn Syndrome
  • B-cells are usually more affected than T-cells
144
Q

What is responsible for diversity of CDRs 1 and 2 in TCRs?

A
  • The multiplicity of V-alpha regions
145
Q

What is the most important contributor to CDR3 diversity in TCRs?

A
  • junctional diversity
146
Q

CD3 proteins

A
  • These are heterodimers that associate with the TCR
  • They are needed in order for TCR to get to cell surface
  • They have Tyrosine-based Activation Motifs (ITAMs) on their intracellular portions, which are crucial in cell signaling
147
Q

TCR-zeta proteins

A
  • These are homodimers that associate with the TCR
  • They have ITAM residues that are important for cell signaling
148
Q

What does TCR recognize?

A
  • peptide fragments on MHC molecules
  • NOT free antigen
149
Q

What is MHC restriction?

A
  • My T-cells will only recognize peptide fragments on MY MHC molecules
  • i.e. My T-cells would not recognize peptide fragment displayed on MHC molecules of another person
150
Q

MHC Class 1 Pathway

A
  • Peptides are presented on MHC1 molecules
  • Antigens are derived from within the cell
  • CD8 T-cells recognize these
151
Q

MHC Class 2 Pathway

A
  • Peptides are presented on MHC2 molecules
  • Antigens are derived from outside the cell
  • CD4 T-cells recognize these
152
Q

Structure of MHC1 molecules

A
  • One heavy chain - the alpha chain. The alpha chain can vary between different MHC molecules
  • One Beta-microglobulin. There is no variation in this molecule. The exact same B-microglobulin complexes with every MHC1 molecule.
153
Q

Structure of MHC2 molecules

A
  • An alpha chain and a beta chain
  • Both chains have variable sequences
154
Q

How do T-cells interact with MHC molecules?

A
  • TCR binds both the peptide fragment and the MHC molecule
  • CDRs 1 and 2 of the TCR bind the MHC molecule
  • CDR 3 of the TCR binds the peptide fragment
155
Q

MHC Class 1 Antigen Processing

A
  • Intracellular antigens
  • Proteasome chews up antigen to generate peptide fragments
  • Fragments transported to endoplasmic reticulum by TAP
  • Binding to MHC1 occurs in ER with the help of Tapasin, ERp57, and Calreticulin
  • After peptide binds MHC1, they are trafficked to cell surface
156
Q

TAP

A
  • Transports antigen peptide fragments from cytosol to ER lumen, where they can bind to MHC1
  • Problems with TAP –> Bare lymphocyte syndrome
157
Q

Bare lymphocyte syndrome

A
  • Caused by dysfunctional TAP protein
  • Can’t get peptide fragments into ER lumen –> can’t get peptide fragments onto MHC1 –> lymphocytes don’t have MHC1 on cell surface
  • Results in high susceptibility to viral infection (recall MHC1 is the main pathway of chewing up viral antigens)
158
Q

Erp57 and Calreticulin

A
  • Proteins that aid in the process of getting peptide fragment bound to MHC1 in the ER lumen
159
Q

MHC Class 2 Antigen Processing

A
  • Antigen is taken up via endocytosis from extracellular space
  • Antigens are chewed up in phagolysosome
  • MHC2 molecules bind peptides in phagolysosome
160
Q

What mechanism prevents MHC2 from binding intracellular fragments (MHC1 fragments) wheile it is in the endoplasmic reticulum?

A
  • Recall MHC1 molecules bind their peptide fragments in ER lumen
  • MHC2 molecules make a stop in the lumen as they are being trafficked to the golgi to bud off as vesicles that will fuse with phagolysosome
  • Invariant chain is a peptide that binds MHC2 molecules while MHC2 is in ER
161
Q

CLIP and HLA-DM

A
  • Once MHC2 molecules get into their vesicles, the invariant chain is digested, leaving a very small molecule - CLIP - bound in the MHC2 groove
  • HLA-DM removes CLIP once MHC2 vesicle fuses with phagolysosome. This results in peptide fragment being able to bind MHC2
162
Q

Summary of MHC1 vs. MHC2 antigen processing pathways

A
163
Q

Role of CD4 and CD8

A
  • These are found on the T-cells
  • Mature T-cells express either CD4 or CD8
  • They bind to MHC molecule at different sites than the TCR binds
  • They’re referred to as co-receptors
164
Q

On what cells are MHC1 molecules expressed?

A
  • All nucleated cells
  • Thus they can be killed by cotytoxic T-cells during a viral immune response
165
Q

On what cells are MHC2 molecules expressed?

A
  • Dendritic cells, B-cells, macrophages, thymic epithelial cells
  • MHC2 molecules are responsible for presenting extracellular pathogens, so MHC2 molecules must only be present on cells that are responsible for presenting these pathogens to T-cells
166
Q

What are the main sources of MHC diversity?

A
  1. Polygeny - in each individual there are multiple genes that encode for class I heavy chains and class II alpha and beta chains
  2. Polymorphism - for each MHC gene there are many different variants within the population
167
Q

What is another name for the MHC locus?

A
  • HLA locus
168
Q

What is the primary cause of transplant rejections?

A
  • Mismatches in MHC expression b/w donor and recipient
169
Q

How is the MHC locus organized?

A
  • MHC1 genes are on the right
    • A,B, and C are the only regions involved in the presentation of antigens
    • These are the genes that encode the alpha chain of MHC1 (The B-microglobulin is not encoded by MHC locus)
  • MHC2 genes are on the left
    • There are 5 clusters. Within each cluster is an alpha chain and beta chain region.
    • Only DP, DQ, and DR regions are involved in antigen presentation
170
Q

What is special about the DR region for MHC2 molecules?

A
  • Humans differ in the number of DR Beta regions they express
  • i.e. Like other MHC2 clusters, DR has a single alpha chain region
  • But unlike the other MHC2 clusters, the DR region has variability in how many beta chain regions there are.
171
Q

HLA polymorphism

A
  • Within a single individual, there can only be 2 different variations of HLA A (and that is only if the individual is heterozygous)
  • But within the population, there are many different variations of MHC molecules expressed
172
Q

Where is most of the variation seen across the population in MHC genes?

A
  • The regions that bind the TCR
  • The regions that bind the peptide
173
Q

What is important about MHC variation?

A
  1. It’s the basis of MHC restriction
    * My T-cells can only recognize my MHC markers because my MHC markers are often genetically different than someone else’s MHC markers. In order to find a transplant match, you need to find people with matching MHCs.
  2. It dictates the type of peptide each MHC molecule can bind
    * Individuals who are heterozygous at more MHC loci are better able to respond to a variety of pathogens
174
Q

How is MHC diversity useful?

A
  • Allows individuals to bind a variety of pathogens
  • Allows populations to bind peptides from a variety of continually changing pathogens
175
Q

How is MHC diversity created? (i.e. new MHC alleles)

A
  1. “Interallelic conversion” - i.e. regular meiotic recombination
  2. “Gene conversion” - i.e. also done during meiosis. Just involves adjacent MHC genes on the same chromosome switching places. Same result as interallelic conversion.
176
Q

What is an MHC haplotype?

A
  • The particular combination of MHC alleles that a person expresses
  • A single individual can express 2 different haplotypes if they are heterozygous
  • There are thousands of different MHC haplotypes within the population
177
Q

How are haplotypes (“types”) important in transplants?

A
  • T-cells from an individual of one HLA type can recognize and respond to (i.e. attack) MHC molecules expressed by an individual
  • In order for transplants to be successful, the two individuals must be of the same HLA type
178
Q

Allogenic

A
  • denoting, relating to, or involving tissues or cells that are genetically dissimilar and hence immunologically incompatible, although from individuals of the same species.
179
Q

Host vs. graft disease

A
  • Host recipient T-cells attack the transplanted tissue
  • Occurs when HLA types between donor and recipient are not compatible.
180
Q

Graft vs. Host disease

A
  • Occurs when T-cells from the donor attack host tissues
  • Occurs during bone marrow transplants (whereas host vs. graft disease is usually an organ transplant)
  • Mature T-lcells from the donor must be completely eradicated before a bone marrow transplant. If they are not, then some of these mature T-cells from the donor will recognize recipient tissue as foreign and attack.
181
Q

Alloreactivity

A
  • A very small portion of T-cells can recognize foreign MHC and attack that cell
  • This is in contrast to MHC restriction, which is still true. The MAJORITY of T-cells can only recognize self MHC.
  • Alloreactivity is the driver of transplant rejections
182
Q

Where do neurons originate from for the sympathetic nervous system?

A
  • Thoracolumbar region of the spine
183
Q

Where do neurons originate for the parasympathetic nervous system?

A
  • Craniosacral regions of the spine
184
Q

Length of preganglionic and postganglionic fibers in sympathetic vs parasympathetic branches

A
  • Parasympathetic: connections are located very close to target organs. (preganglionic neurons are very long)
  • Sympathetic: connections are located very close to spine (preganglionic neurons are very short)
185
Q

Which organs are innervated only by the sympathetic nervous system?

A
  • Sweat glands
  • Adrenal gland
  • Blood vessels
186
Q

Signaling of parasympathetic vs sympathetic

A
  • Sympathetic is usually felt as systemic effects. This is because adrenal gland releases NE into bloodstream.
  • Parasympathetic is usually more discrete to particular organ
187
Q

Preganglionic neurotransmitter

A
  • Always acetylcholine (for both sympathetic and parasympathetic)
188
Q

postganglionic neurotransmitter for parasympathetic NS

A
  • acetylcholine
189
Q

postganglionic NT for sympathetic nervous system

A
  • epinephrine/norepinephrine
  • **Except for sweat glands, which uses acetylcholine for sympathetic response
  • **Adrenal gland does not have a postganglionic receptor. It releases NE directly into bloodstream
190
Q

Acetylcholine receptor subtypes

A
  • Nicotinic
    • Voltage-gated ion channel
    • Increases calcium or sodium
  • Muscarinic
    • GPCR
    • Increases calcium OR
    • Decreases cAMP/Increases K+
191
Q

Norepinephrine receptor subtypes

A
  • Adrenergic receptors
    • Alpha
    • Beta
192
Q

Vascular responses

A
  • Only under sympathetic control
  • Epinephrine binds alpha1 receptor in SMOOTH muscle, which increases calcium
    • Causes Increased smooth muscle contraction –> vasoconstriction
  • Epinephrine binds beta2 receptor in SKELETAL muscle, which decreases cAMP and decreases calcium
    • Causes vasodilation in skeletal muscle
193
Q

Adrenal response

A
  • Only innervated by sympathetic nervous system
  • Preganglionic receptor is cholinergic nicotinic, which acetylcholine binds
  • There is no postganglionic receptor.
  • When Ach binds, NE is released into bloodstream.
194
Q

Sweat gland response

A
  • There is only sympathetic innervation here
  • **But this is an exception, which is that acetylcholine is the primary NT for sweat glands. In all other sympathetic situations, it’s epinephrine.
  • Ach binds muscarinic receptor
  • Causes increased sweat production
195
Q

Cardiac responses

A
  • Parasympathetic
    • Ach binds muscarinic receptor in two different places: SA/AV nods and cardiac myocytes
    • SA/AV nodes –> decreased rate of contraction
    • Cardiac myocytes –> Decreases force of contraction
  • Sympathetic
    • NE binds B-adrenergic receptor in two different places: SA/AV nodes and cardiac myocytes
    • SA/AV nodes –> Increases HR
    • Cardiac myocytes –> Increases force of contraction
196
Q

What is unique about cardiac responses?

A
  1. Rate of contraction is dictated by receptors on SA/AV nodes (pacemaker node), while force of contraction is dictated by receptors directly on cardiac myocytes
  2. Normally we say calcium increases smooth muscle contraction and cAMP causes relaxation. But that only applies to SMOOTH MUSCLE. Cardiac muscle is not smooth muscle. In the heart, cAMP does result in increased force and increased rates of contraction. Inhibition of cAMP by parasympathetic muscarinic receptors decreases force and rate of contraction.
197
Q

Pulmonary responses

A
  • Sympathetic –> bronchoconstriction and increased secretions. Results from increased calcium.
  • Parasympathetic –> bronchodilation and decreased secretions
198
Q

Urinary responses

A
  • Parasympathetic –> more peeing. Results from sphincter muscle relaxation but contraction of detrusor muscle
  • Sympathetic –> less peeing. Results from sphincter muscle contraction but relaxation of detrusor muscle.
199
Q

Occular responses

A
  • Sympathetic –> pupil dilation
    • NE causes CONTRACTION of circular muscles (=miosis)
  • Parasympathetic –> pupil constriction
    • Ach causes CONTRACTION of radial muscles (=mydriasis)
200
Q

Acetylcholinesterase

A
  • Degrades acetylcholine in the synapse
201
Q

Muscarinic receptor subtypes

A
  • M1, M3, M5 –> calcium results in excitatory signal
  • M2, M4 –> lower cAMP and increase K+ –> inhibitory
202
Q

Subtypes of cholinergic nicotinic receptors

A
  • Neuronal (found at ganglia of all receptors, both sympathetic and parasympathetic, making these clinically useless drug targets)
  • Muscular - found at neuromuscular junction
203
Q

Where is M2 found?

A
  • In the heart
  • Acetylcholine binds this and it inhibits cAMP and leads to a potassium efflux –> hyperpolarization.
  • This hyperpolarization means that any further stimulation will not have an affect, which is why this is an inhibitory response.
204
Q

Acetylcholine

A
  • Binds muscarinic and nicotinic receptors
  • Is positively charged so cannot cross the blood-brain barrier
  • Therapeutic use: Used locally to prep for eye surgery
    • Causes pupillary constriction by making circular muscles contract
  • Therapeutic effect: pupillary constriction
  • Toxic effects: decreased HR, decreased force of contraction. Bronchoconstriction.
205
Q

What is the effect of Ach on blood vessels?

A
  • There is no parasympathetic stimulation of blood vessels
  • BUT there are M3 receptors in blood vessels, which Ach binds
  • Results in increased calcium –> nitric oxide synthesis, which diffuses out to the smooth muscle and causes relaxation –> vasodilation
  • ***Normally we think of calcium causing smooth muscle contraction, but this is different.
206
Q

What is the impact of acetylcholinesterase inhibitors?

A
  • Inhibit degradation of acetylcholine in the synapse
  • Result in amplification of Ach
207
Q

Reversible acetylcholinesterase inhibitors

A
  • Edrophonium
  • Pyridostigmine
  • Physostigmine
  • Donezapil
208
Q

Edrophonium

A
  • Is a competitive inhibitor of acetylcholinesterase, does not form covalent intermediate
209
Q

Pyridostigmine

A
  • This is a carbamate
  • Forms a covalent intermediate in acetylcholinesterase binding pocket that is slowly reversible
  • Used to treat Myasthenia Gravis
210
Q

Physostigmine

A
  • Also a carbamate, forms a covalent intermediate with acetylcholinesterase binding pocket
  • Used to treat overdose of muscarinic antagonist (i.e. atropine)
211
Q

Donezapil

A
  • Does not form a covalent intermediate, but it lasts so long b/c the drug’s half life is extremely long
  • Used to treat Alzheimer’s
212
Q

Irreversible acetylcholinesterase inhibitors

A
  • Many of these are poisonous
  • Diisopropyl flourophosphate = insecticide
  • Sarin = nerve gas
  • These can all cross the blood-brain barrier
  • Toxicity: DUMBBELS
213
Q

DUMBBELS

A
  • Mnemonic for toxicity that results from acetylcholinesterase inhibition (too much acetylcholine amplification)
  • D = diarrhea
  • U = urination
  • M = miosis (pupillary constriction)
  • B = bradycardia (slow HR)
  • B = bronchorrhea (too much secretions)
  • E = emesis (vomiting)
  • L = lachrymation (tears/crying)
  • S = salivation
  • **These are all results of overstimulation of parasympathetic nervous system**
214
Q

Cholinesterase regenerator

A
  • Pralidoxime
  • Acts as an antidote for the irreversible inhibitors
  • Mechanism: reverses inhibition of acetylcholinesterase
  • Therapeutic use: antidote for pesticide or nerve gas poisoning
  • Therapeutic effect: reverses DUMBBELS
  • Toxic effects: At very high doses, can itself inhibit acetylcholine
215
Q

Pralidoxime

A
  • Acts as an antidote for the irreversible inhibitors
  • Mechanism: reverses inhibition of acetylcholinesterase
  • Therapeutic use: antidote for pesticide or nerve gas poisoning
  • Therapeutic effect: reverses DUMBBELS
  • Toxic effects: At very high doses, can itself inhibit acetylcholine
216
Q

Botulinum Toxin

A
  • This is BOTOX
  • Mechanism: Inhibits the release of Acetylcholine
  • Therapeutic use: reduces wrinkles
  • Therapeutic effect: local muscle paralysis
  • Toxic effects (due to escape from injection site):
    Neuromuscular weakness, respiratory depression
217
Q

B-cell vs T-cell

A
218
Q

BCR intracellular signaling vs. TCR intracellular signaling

A
  • BCR signaling occurs via Ig-alpha and Ig-beta
  • TCR signaling occurs via CD3 and TCR zeta ITAMS
219
Q

What is the receptor type found on adrenal gland?

A
  • Nicotinic cholinergic
  • This is one place acetylcholine stimulates sympathetic response
220
Q

What is the receptor type found on sweat glands?

A
  • Muscarinic cholinergic
  • This is the second place acetylcholine stimulates sympathetic response
221
Q

Two locations where acetylcholine stimulates a sympathetic response

A
  • Adrenal gland (nicotinic cholinergic receptor)
  • Sweat glands (muscarinic cholinergic receptor)